156 related articles for article (PubMed ID: 15798769)
1. Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.
Pritchard-Jones K; Spendlove I; Wilton C; Whelan J; Weeden S; Lewis I; Hale J; Douglas C; Pagonis C; Campbell B; Alvarez P; Halbert G; Durrant LG
Br J Cancer; 2005 Apr; 92(8):1358-65. PubMed ID: 15798769
[TBL] [Abstract][Full Text] [Related]
2. T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Kallmeyer C; Pritchard-Jones K; Durrant LG
Clin Immunol; 2008 Aug; 128(2):148-54. PubMed ID: 18508409
[TBL] [Abstract][Full Text] [Related]
3. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
[TBL] [Abstract][Full Text] [Related]
4. 105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.
Durrant LG; Buckley DJ; Robins RA; Spendlove I
Int J Cancer; 2000 Jan; 85(1):87-92. PubMed ID: 10585589
[TBL] [Abstract][Full Text] [Related]
5. A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.
Durrant LG; Maxwell-Armstrong C; Buckley D; Amin S; Robins RA; Carmichael J; Scholefield JH
Clin Cancer Res; 2000 Feb; 6(2):422-30. PubMed ID: 10690519
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
[TBL] [Abstract][Full Text] [Related]
7. Low doses of 105AD7 cancer vaccine preferentially stimulate anti-tumor T-cell immunity.
Durrant LG; Buckley DJ; Spendlove I; Robins RA
Hybridoma; 1997 Feb; 16(1):23-6. PubMed ID: 9085124
[TBL] [Abstract][Full Text] [Related]
8. Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responses.
Buckley DT; Robins AR; Durrant LG
Hum Antibodies Hybridomas; 1995; 6(2):68-72. PubMed ID: 7492753
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.
Maxwell-Armstrong CA; Durrant LG; Buckley TJ; Scholefield JH; Robins RA; Fielding K; Monson JR; Guillou P; Calvert H; Carmichael J; Hardcastle JD
Br J Cancer; 2001 Jun; 84(11):1443-6. PubMed ID: 11384090
[TBL] [Abstract][Full Text] [Related]
10. Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responses.
Durrant LG; Parsons T; Moss R; Spendlove I; Carter G; Carr F
Int J Cancer; 2001 May; 92(3):414-20. PubMed ID: 11291080
[TBL] [Abstract][Full Text] [Related]
11. Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7.
Maxwell-Armstrong CA; Durrant LG; Robins RA; Galvin AM; Scholefield JH; Hardcastle JD
Gut; 1999 Oct; 45(4):593-8. PubMed ID: 10486371
[TBL] [Abstract][Full Text] [Related]
12. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
[TBL] [Abstract][Full Text] [Related]
13. Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.
Maxwell-Armstrong C
Ann R Coll Surg Engl; 2002 Sep; 84(5):314-8. PubMed ID: 12398121
[TBL] [Abstract][Full Text] [Related]
14. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
15. Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma.
Himoudi N; Wallace R; Parsley KL; Gilmour K; Barrie AU; Howe K; Dong R; Sebire NJ; Michalski A; Thrasher AJ; Anderson J
Clin Transl Oncol; 2012 Apr; 14(4):271-9. PubMed ID: 22484634
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7.
Durrant LG; Buckley TJ; Denton GW; Hardcastle JD; Sewell HF; Robins RA
Cancer Res; 1994 Sep; 54(18):4837-40. PubMed ID: 8069847
[TBL] [Abstract][Full Text] [Related]
19. Decay accelerating factor (CD55): a target for cancer vaccines?
Spendlove I; Li L; Carmichael J; Durrant LG
Cancer Res; 1999 May; 59(10):2282-6. PubMed ID: 10344729
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.
Denton GW; Durrant LG; Hardcastle JD; Austin EB; Sewell HF; Robins RA
Int J Cancer; 1994 Apr; 57(1):10-4. PubMed ID: 8150527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
